Company: DERM
Filing Date: 2025-07-14
Form Type: 8-K
Source: 0001104659-25-067767
Chunk: 0

Company: Journey Medical Corp
Filing Date: 2025-07-14
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01      Other Events.  

On July 14, 2025, Journey
Medical Corporation (the “Company”) announced an expansion in pharmacy benefit coverage for Emrosi™ (40 mg Minocycline
Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release), the Company’s recently launched treatment
for the inflammatory lesions of rosacea in adults. A copy of the press release issued by the Company is attached hereto as Exhibit 99.1
and incorporated herein by reference.